UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.96 -0.04 (-0.05%) GOLD FUTURES
2,311.90 +0.90 (+0.04%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,339.59 +1,962.49 (+4.32%)
Eli Lilly and Co (LLY.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
At close: 08:07AM CEST
| Previous close | 692.30 |
| Open | 726.70 |
| Bid | 704.00 x 0 |
| Ask | 705.40 x 0 |
| Day's range | 726.70 - 726.70 |
| 52-week range | 385.20 - 736.50 |
| Volume | |
| Avg. volume | 8 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Yahoo Finance
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
- Barrons.com
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
- Insider Monkey
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]
© 2024 Yahoo. All rights reserved.